Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2820 of 5804
-
Laughing gas may soothe painful tube insertion in toddlers
Symptom relief CompletedSince nitrous oxide/oxygen mixture is effective to reduce pain and anxiety induced by various painful procedures in children, the investigators hypothesized that its inhalation would reduce pain during nasogastric tube placement in young children. The purpose of this study is to…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Why COVID-19 lungs fail: tiny blood vessel damage may be key
Knowledge-focused CompletedThe primary endpoint of this research is to establish that the alveolar dead space is significantly higher in patients with COVID-19 ARDS, compared to patients with non-COVID-19 ARDS. Secondarily, the investigators want to establish the prognostic value of the alveolar-dead spac…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Can a registry help more families get tested for cancer genes?
Knowledge-focused CompletedThe purpose of this study is to compare the uptake rates of a patient-initiated model of cascade testing with a registry-aided model amongst relatives of patients identified to have a particular cancer predisposition gene. Cascade testing allows the benefits of genetic testing to…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Can smartphone apps help fight addiction in primary care? large study tests new approach.
Knowledge-focused CompletedThe DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and K…
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Magnetic stent removal spares kids from anesthesia
Symptom relief CompletedDouble-J ureteral stent (DJUS) is one of the most common devices used in urology. Ureteral stenting has a wide spectrum of indications that can be summarized in two words: obstruction and leakage. Common indications in pediatric urology are pyeloplasty, ureteral reimplantation, k…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New antibacterial plate aims to cut infection risk in broken ankles
Disease control Completedaap001 is a randomized, controlled, subject-blinded, multi-center study to show the safety of the LOQTEQ® antibacterial silver-coated system is non-inferior in comparison with the uncoated LOQTEQ® system
Phase: NA • Sponsor: aap Implantate AG • Aim: Disease control
Last updated Jun 26, 2026 18:41 UTC
-
New cocktail for Tough-to-Treat myeloma shows promise in early trial
Disease control OngoingThis study is a Phase Ib, open label, single arm, adaptive multi-centre clinical study. The target population for this study are patients with relapsed/refractory multiple myeloma (MM). Patients will have a confirmed diagnosis of MM, with measurable disease as per IMWG criteria, …
Phase: PHASE1 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a hearing aid keep veterans out of the ER?
Symptom relief Recruiting nowHearVA involves six VA facility emergency departments (ED) over a 3-year intervention period. The first part of this study will test whether providing personal amplifiers to Veteran ED patients who self-report hearing difficulty is acceptable to these patients, can improve their …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Experimental lymphoma drug combo shows promise in early trial
Disease control TerminatedThis is a phase 2 multi-cohort, un-controlled, non-randomized, open-label, multi-center study that assessed the antitumor activity and safety of non-alpha interleukin (IL-2) SAR444245 with or without other anticancer therapies in participants aged 12 years and older with relapsed…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New bladder cancer drug delivered directly into bladder shows early promise
Disease control TerminatedThis study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug d…
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New cream shows promise for rare skin condition
Disease control CompletedIn this phase I/II trial a topical skin cream with the active substance SXR1096 will be tested in patients with Netherton syndroms, a rare inflammatory skin disease. SXR1096 is a specific and potent protease inhibitor that can inhibit the proteases kallikrein 5, 7 and 14 - all re…
Phase: PHASE1, PHASE2 • Sponsor: Sixera Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New clip fixes leaky heart valve without open surgery
Disease control CompletedThe MitraClip System is the first commercially available catheter-based option for the treatment of MR. The MitraClip System was developed as an alternate percutaneous technology which may serve as a viable therapeutic option for open-heart surgery. Treatment with the MitraClip d…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a cord tissue injection ease severe knee arthritis?
Symptom relief CompletedIt is hypothesized that a single Intra-articular Injection of TTAX03, 100mg in 2mL of saline, will have more benefit with respect to the proportion of responders 12 weeks post-injection than an equal volume of saline, based on the OMERACT-OARSI responder criteria.
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated Jun 26, 2026 19:12 UTC
-
AI analyzes 10,000 patient records to predict head and neck cancer recurrence
Knowledge-focused CompletedThis will be an international, multicenter, retrospective, observational, and data-driven study using secondary data captured in EHRs. The extraction of the data captured in the EHRs will be performed with SAVANA's EHRead®, an innovative data-driven system based on Natural Langua…
Sponsor: Savana Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Could flickering lights and tones boost brain health in down syndrome?
Knowledge-focused Recruiting nowDown Syndrome (DS) is characterized by an additional copy of chromosome 21, which also increases risk of Alzheimer's Disease (AD). The investigators' lab found a non-invasive way to remove toxic proteins from the brain in AD mouse models. Remarkably, treated mice also have improv…
Phase: NA • Sponsor: Massachusetts Institute of Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can a donor skin patch stop rotator cuff tears from coming back?
Disease control Recruiting nowThe Investigators are planning to conduct a Pilot study of 40 patients of Pragmatic randomised controlled trial comparing rotator cuff tendons repair (small tendons around the shoulder ) with or without augmentative patch. It includes patients between age groups 50 to 75 years wi…
Phase: PHASE4 • Sponsor: University Hospitals, Leicester • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a simple ultrasound replace radiation scans for kidney blockages?
Diagnosis CompletedThis research is studying Definity ultrasound contrast agent, which is already approved by the Food and Drug Administration (FDA) for the ultrasound evaluation of the liver and heart. This research will investigate the ability to use ultrasound imaging with ultrasound contrast ag…
Phase: PHASE2 • Sponsor: University of Michigan • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
New pill plus injection shows promise for Crohn's – but trial halted early
Disease control TerminatedThis study is open to adults, aged 18-75 years, with moderate to severe Crohn's disease. The purpose of this study is to find out whether BI 706321 combined with ustekinumab helps people with Crohn's disease. BI 706321 is a medicine being developed to treat Crohn's disease. Uste…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 26, 2026 13:28 UTC
-
Shock therapy for bladder troubles: new hope for MS patients?
Symptom relief Recruiting nowThe present trial is designed to assess the efficacy and safety of transcutaneous tibial neuro-stimulation (TTNS) in improving bladder emptying in multiple sclerosis (MS) patients. Patients presenting with MS and performing clean intermittent self-catheterization (CISC) to empty…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Fish oil pills may ease autism symptoms in young kids
Symptom relief CompletedThe objective of the protocol is to test the impact of Omega 3-6 on pre-specified biological signatures (IL-1β, IL-2, and IFNγ) and to correlate changes in the biological signatures with changes in ASD symptoms.
Phase: PHASE2 • Sponsor: Sarah Keim • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC